Imagen de Portada

Expansion of the Phenotype of Lymphatic Anomalies Caused by Somatic Activating BRAF Variant

Fuente: Wiley Open Access

Guardado en:

Detalles Bibliográficos
Autores principales:	Michael D. Fox, Sumukh Kumar, Allison D. Britt, Abhay S. Srinivasan, Lea F. Surrey, Seth E. Vatsky, Alexandra J. Borst, Hakon Hakonarson, Dong Li, Sarah E. Sheppard, Kristen M. Snyder, Denise M. Adams
Formato:	Artículo Open Access
Publicado:	Wiley 2025
Materias:	Pediatric Blood & Cancer
Acceso en línea:	Acceder al recurso
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

VA‐Comm: Developing and Piloting a Novel Communication Tool for Complex Lymphatic Anomalies and Lymphatic Malformations
por: Bryan A. Sisk, et al.
Publicado: (2025)

Lyve1‐Driven NrasQ61R Causes Edema, Enlarged Lymphatic Vessels, and Hepatic Vascular Defects in Embryonic Mice
por: C. Griffin McDaniel, et al.
Publicado: (2024)

Human Lymphatic Endothelial Cells Expressing NRASQ61R Model Characteristics of Kaposiform Lymphangiomatosis
por: Dermot A. Fox, et al.
Publicado: (2025)

The implementation of molecular tumor profiling in the practice of pediatric cancer pathology: The pathologists’ experience
por: Catherine K. Gestrich, et al.
Publicado: (2024)

NRAS Q61R Expression in Lymphatic Endothelial Cells Causes Enlarged Vessels, Hemorrhagic Chylous Effusions, and High Mortality in a Mouse Model of Kaposiform Lymphangiomatosis
por: C. Griffin McDaniel, et al.
Publicado: (2026)

Severe Hemolytic Phenotype in Children With Sickle Cell Anemia and Co‐Inherited Red Blood Cell Variants
por: Meghana Srinivas, et al.
Publicado: (2025)

An infant with severe neonatal immune thrombocytopenia and gradual resumption of breastfeeding
por: Zaina Inam, et al.
Publicado: (2024)

The Clinical Impact of Somatic Copy Number Variations in Patients With Stage IV Wilms Tumor Enrolled in the SIOP 2001 Trial and Study
por: Nils Welter, et al.
Publicado: (2025)

Concurrent Somatic Mutations of the SETBP1 and KRAS Genes in Pediatric AML: A Case Report
por: Ryo Okuse, et al.
Publicado: (2026)

BRAF/MEK inhibitors use to treat ventriculoperitoneal shunt‐associated ascites in pediatric low‐grade gliomas
por: Nisreen Amayiri, et al.
Publicado: (2024)

Image‐Guided Biopsy for the Diagnosis and Molecular Profiling of Hepatoblastoma
por: Sean Schoeman, et al.
Publicado: (2025)

Transforming Pediatric Oncology Research: The Role of Collaboration, Precision Medicine, and Evolving Study Designs
por: Shyam Srinivasan
Publicado: (2024)

Molecularly Informed Combination Therapy for BRAF‐KIAA1549 Fusion‐Positive Pilocytic Astrocytoma in a Resource‐Limited Setting
por: Yousef VatanParast
Publicado: (2025)

Percutaneous biopsy for the diagnosis, risk stratification, and molecular profiling of neuroblastoma: A single‐center retrospective study
por: Sean Schoeman, et al.
Publicado: (2024)

Access Program for Unapproved and Off‐Label Drug Use in Pediatric BRAF V600E‐Mutated Brain Tumors in Japan
por: Maya Suzuki, et al.
Publicado: (2025)

Ocular Safety and Visual Acuity Stability in Pediatric Patients With Optic Pathway Gliomas and Orbital Plexiform Neurofibromas Treated With BRAF and MEK Inhibitors
por: Aviv Sever, et al.
Publicado: (2025)

Congenital Myelodysplastic Syndrome in a Newborn With Germline JAK2 Variant Treated With Liposomal Cytarabine–Daunorubicin and Allogeneic Hematopoietic Stem Cell Transplant
por: Kristin E. Zorn, et al.
Publicado: (2025)

Genomic and Clinicopathological Characterization of CRLF2‐Rearranged Mixed Phenotype Acute Leukemia
por: Lina Han, et al.
Publicado: (2025)

Cerebrospinal Fluid Liquid Biopsy Enables Targeted Therapy Without Tissue Diagnosis in Pediatric Low‐Grade Gliomas With BRAF V600E Mutation
por: Hannah Sultan, et al.
Publicado: (2026)

BRAF‐V600E mutations in plasma and peripheral blood mononuclear cells correlate with prognosis of pediatric Langerhans cell histiocytosis treated with first‐line therapy
por: Chan‐Juan Wang, et al.
Publicado: (2024)

Rapid remission of life‐threatening chylo‐ascites with dabrafenib and trametinib combination in complex lymphatic anomaly with pathogenic somatic BRAF and PIK3CA co‐variation
por: Mathias Yuan, et al.
Publicado: (2024)

Activity of the MEK inhibitor trametinib in a patient with a BRAF mutation persisting from T‐lymphoblastic lymphoma through lineage switch to CNS acute myeloid leukemia
por: Wallace Bourgeois, et al.
Publicado: (2024)

A Rare Case of Pediatric BRAF V600E‐Mutated Erdheim–Chester Disease With Isolated Central Nervous System Onset: Diagnosis, Treatment, and Efficacy Evaluation
por: Jing Ni, et al.
Publicado: (2026)

Pathogenic Germline PALB2 and RAD50 Variants in Patients With Relapsed Ewing Sarcoma
por: Molly Mack, et al.
Publicado: (2026)

Comment on: “Challenging the Odds: Long‐Term Survival in Pediatric Diffuse Midline Glioma With H3 K27M and BRAF V600 Co‐Mutations Treated With Upfront Radiotherapy and Targeted Therapy”
por: Natália Dassi, et al.
Publicado: (2026)

Sickle Cell Story Club: Implementation of a Clinic‐Based Literacy Promotion Program
por: Julia E. LaMotte, et al.
Publicado: (2025)

Phenotypic heterogeneity associated with a novel MECOM variant: Mild thrombocytopenia to hydrops fetalis
por: Sue L. Jaspersen, et al.
Publicado: (2024)

Ghosal Type Hematodiaphyseal Dysplasia—A Rare and Unusual Cause of Cytopenias
por: Sirisha Rani Siddaiahgari, et al.
Publicado: (2025)

Comparing Absolute Neutrophil Counts of Children With Sickle Cell Disease With and Without the Duffy Null Phenotype
por: Nate Goldfarb, et al.
Publicado: (2025)

Pediatric and Adolescent Rectal Adenocarcinoma: A National Cancer Database Analysis and Comparison to Adults
por: Michael H. Froehlich, et al.
Publicado: (2026)

Comment on: Novel Findings in Pediatric and Adolescent Patients With Cancer and a Germline SMARCA4 Variant. First Familial Case of Neuroblastoma in a Mother–Daughter Pair With a Shared Germline SMARCA4 Variant
por: Dildar Bahar Genc, et al.
Publicado: (2025)

Coagulation Dysfunction Caused by a De Novo Mutation of Gene SLC37A4
por: Mauro Guariento, et al.
Publicado: (2024)

Oral and Dental Management in Children With Congenital Neutropenia
por: Dany A. Curi, et al.
Publicado: (2025)

MEK Inhibition Reduces Vascular Malformations and Gene Dysregulation in NRAS Q61R Human Endothelial Cells
por: Sara Alharbi, et al.
Publicado: (2026)

Novel Pediatric Aggressive Adipose Tumor With Pathogenic TERT Promoter Variant and an Initial Durable Response to Vincristine and Dactinomycin
por: Lucy Hare, et al.
Publicado: (2026)

Case of Refractory Classic Hodgkin Lymphoma With a Germline Pathogenic Monoallelic Variant in the TNFRSF13B Gene
por: Mónica Camacho‐Arias, et al.
Publicado: (2024)

A Novel Gain‐of‐Function RAC2 Variant (p.Y64H) Associated With Lymphopenia and Leukopenia
por: Yeşim Haliloğlu, et al.
Publicado: (2026)

NRAS Q61R mutation drives elevated angiopoietin‐2 expression in human endothelial cells and a genetic mouse model
por: Patricia Pastura, et al.
Publicado: (2024)

A Rare Case of Acute Leukemia With CBFA2T3::GLIS2 Fusion Exhibiting a T/Megakaryocyte Mixed Phenotype
por: Qiang Yao, et al.
Publicado: (2025)

Emergency department 30‐Day emergency department revisits among people with sickle cell disease: Variations in characteristics
por: Melinda Rushing, et al.
Publicado: (2024)